Lizhen Xu
Papers
1
Total Citations
9
H-Index
1
About
Lizhen Xu is a clinical researcher whose work centers on urologic oncology, with a particular focus on comparing surgical outcomes in prostate cancer treatment. Her most cited study, "Health-related quality of life in robotic versus open radical prostatectomy" (2015, 9 citations), addresses a critical question in surgical oncology: whether robot-assisted radical prostatectomy (RARP) offers superior health-related quality of life (HRQoL) outcomes compared to traditional open radical prostatectomy (ORP). By retrospectively analyzing patient records from 2009 to 2012, Xu provides valuable real-world evidence that helps clinicians and patients weigh the benefits of minimally invasive techniques against conventional approaches. This work contributes to the ongoing debate about surgical innovation and patient-centered outcomes, highlighting the importance of functional recovery alongside cancer control. Xu’s research is particularly relevant for urologists, oncologists, and health outcomes researchers seeking to optimize treatment decisions. With a growing citation base, Xu’s contributions continue to inform evidence-based practice in prostate cancer surgery, making her a notable voice in the field of surgical quality-of-life research.
Research Focus
Key Achievements
Top Papers
- 1